14-3-3 facilitates insulin-stimulated intracellular trafficking of insulin receptor substrate 1

Mol Endocrinol. 2002 Mar;16(3):552-62. doi: 10.1210/mend.16.3.0790.

Abstract

The appearance of a complex between tyrosine-phosphorylated insulin receptor substrate 1 (IRS-1) and PI3K in a high-speed pellet fraction (HSP) is thought to be a key event in insulin action. Conversely, the disappearance of the IRS-1/PI3K complex from this fraction has been linked to insulin desensitization. The present study examines the role of 14-3-3, a specific phospho-serine binding protein, in mediating the disappearance of IRS-1 from the HSP after insulin treatment. An in vitro pull-down assay using recombinant 14-3-3 revealed that insulin enhances the association of 14-3-3 with IRS-1 in cultured adipocytes and that this is completely inhibited by wortmannin. An association of IRS-1 and 14-3-3 was also observed and was maximal after stimulation by insulin, when endogenous proteins were immunoprecipitated. Epidermal growth factor (EGF), 12-O-tetradecanoylphorbol-13-acetate, and okadaic acid, other agents that cause serine/threonine phosphorylation of IRS-1, also stimulated IRS binding to 14-3-3. The enhancement of IRS-1 binding to 14-3-3 by insulin was accompanied by movement of IRS-1 and the p85 subunit of PI3K from the HSP to the cytosol. In keeping with a key role of 14-3-3 in mediating this redistribution of IRS-1, the complexes of IRS-1 and 14-3-3 were found in the cytosol but not in the HSP of insulin-treated cells. In addition, colocalization of IRS-1 and 14-3-3 was observed in the cytoplasm after insulin treatment by confocal microscopy. Finally, the addition of a phosphorylated 14-3-3 binding peptide to an adipocyte homogenate (to remove 14-3-3 from IRS-1) increased the abundance of IRS-1/PI3K complexes in the HSP and decreased their abundance in the cytosol. These findings strongly suggest that 14-3-3 participates in the intracellular trafficking of IRS-1 by promoting the displacement of serine-phosphorylated IRS-1 from particular structures. They also suggest that 14-3-3 proteins could play an integral role in the process of insulin desensitization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 14-3-3 Proteins
  • 3T3 Cells
  • Animals
  • Biological Transport
  • COS Cells
  • Cell Nucleus / chemistry
  • Cytoplasm / chemistry
  • Cytosol / metabolism
  • Enzyme Inhibitors / pharmacology
  • Epidermal Growth Factor / pharmacology
  • Fluorescent Antibody Technique
  • Immunosorbent Techniques
  • Insulin / pharmacology*
  • Insulin Receptor Substrate Proteins
  • Kinetics
  • Mice
  • Microscopy, Confocal
  • Okadaic Acid / pharmacology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphoproteins / analysis
  • Phosphoproteins / metabolism*
  • Phosphorylation
  • Phosphoserine / metabolism
  • Phosphothreonine / metabolism
  • Phosphotyrosine / metabolism
  • Recombinant Proteins / pharmacology
  • Tetradecanoylphorbol Acetate / pharmacology
  • Transfection
  • Tyrosine 3-Monooxygenase / analysis
  • Tyrosine 3-Monooxygenase / metabolism
  • Tyrosine 3-Monooxygenase / pharmacology*

Substances

  • 14-3-3 Proteins
  • Enzyme Inhibitors
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, mouse
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphoproteins
  • Recombinant Proteins
  • Phosphothreonine
  • Phosphoserine
  • Okadaic Acid
  • Phosphotyrosine
  • Epidermal Growth Factor
  • Tyrosine 3-Monooxygenase
  • Tetradecanoylphorbol Acetate